Snapshot · CVS Health Corp. (CVS)

Data as of 2026-10-19T04:33:10.054Z

Fundamentals check

Market cap

$118.1B

P/E (TTM)

24.1

Gross margin

14.2%

Net margin

1.2%

ROE

6.4%

R&D / revenue

0.0%

Dividend yield

2.9%

FCF yield

10.0%

Latest dividend: $0.665/share (ex-date 2026-10-22, quarterly)

Summary

CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.

How it makes money

Revenue mix, latest fiscal year

• Pharmacy Revenue58.9%
• Premiums34.6%
• Front Store Revenue5.5%
• Product and Service, Other1%

Recent Events

• 2026-10-16T10:41:14.000Zneutral

  Why CVS Health (CVS) is a Top Value Stock for the Long-Term

  分析文章提供长期价值视角，未直接指示因果；对投资者情绪可能有提醒作用。

  Source: zacks.com

• 2026-10-15T18:45:58.000Zpositive

  CVS Health (CVS) Exceeds Market Returns: Some Facts to Consider

  报道显示相对市场的收益提升，可能与股价走高相关，但不构成因果断言。

  Source: zacks.com

• 2026-10-15T09:00:00.000Zpositive

  CVS Health collaborates with The Midlife Collective to redefine a woman's midlife health journey

  企业合作新闻可能提升品牌形象，对股价产生积极情绪但非确定因果。

  Source: prnewswire.com

• 2026-10-14T12:55:00.000Zneutral

  CVS vs. ALHC: Which Medicare Advantage Stock Is the Better Pick Now?

  市场对比分析，未给出明确因果关系，信息帮助投资者比较。

  Source: Zacks Investment Research

• 2026-10-14T10:32:53.000Znegative

  CVS to pay $315 million settlement to resolve DOJ opioid lawsuit

  可能与司法诉讼结案相关的负面消息，对股价有潜在压力，但不等同于因果。

  Source: fastcompany.com

• 2026-10-14T00:00:00.000Zpositive

  Price move: CVS rose 3.2%

  CVS 在这段行情中出现明显波动，恰逢异常的价格变动，但此处没有可关联到的具体新闻事件。

• 2026-10-13T14:53:00.000Znegative

  Did CVS Health Corporation Insiders Breach their Fiduciary Duties to Shareholders?

  调查性新闻，潜在负面情绪，需等待司法或官方结论，非因果断言。

  Source: prnewswire.com

• 2026-10-13T14:42:00.000Znegative

  CVS Health Unit to Pay $315 Million to Resolve Illegal Opioid Prescription Claims

  司法和合规相关负面消息，可能影响投资者信心。

  Source: wsj.com

• 2026-10-12T10:31:13.000Zpositive

  Wall Street Bulls Look Optimistic About CVS Health (CVS): Should You Buy?

  分析师乐观情绪可能提振投资者信心，但不构成直接因果。

  Source: zacks.com

• 2026-10-09T20:10:00.000Znegative

  CVS Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of CVS Health Corporation - CVS

  调查性新闻可能带来负面情绪；尚未定性结论，非因果断言。

  Source: prnewswire.com

• 2026-10-09T11:59:00.000Znegative

  CVS Stock Dips After Drop in Medicare Advantage Plan Ratings

  医保计划评级下滑带来压力性新闻，可能影响情绪但非直接因果。

  Source: barrons.com

• 2026-10-09T08:42:02.000Znegative

  Humana Soars 16% on Improved Medicare Advantage Star Ratings; CVS Slides 3%, UnitedHealth Holds Steady

  行业比较新闻对CVS负面情绪的反应，属于市场相关报道，非因果断言。

  Source: 247wallst.com

• 2026-10-08T16:21:00.000Zneutral

  CVS Health Trades at a Discount to Industry: How to Play the Stock?

  行业对比分析，提供投资线索但非直接因果。

  Source: Zacks Investment Research

• 2026-10-08T12:45:03.000Zpositive

  Here's Why CVS Health (CVS) is a Strong Growth Stock

  增长前景分析带来积极情绪，非因果断言。

  Source: Zacks Investment Research

• 2026-10-07T20:45:04.000Zpositive

  CVS Health (CVS) Advances While Market Declines: Some Information for Investors

  在市场走弱时的相对表现新闻，可能提振情绪但非因果。

  Source: Zacks Investment Research

• 2026-10-07T12:00:05.000Zneutral

  Is Most-Watched Stock CVS Health Corporation (CVS) Worth Betting on Now?

  投资者关注度与评估新闻，非直接因果断言。

  Source: Zacks Investment Research

• 2026-09-25T00:00:00.000Zpositive

  Price move: CVS rose 4.8%

  CVS 在这段行情中出现明显波动，恰逢异常的价格变动，但此处没有可关联到的具体新闻事件。

• 2026-09-01T00:00:00.000Zpositive

  Price move: CVS rose 3.9%

  CVS 在这段行情中出现明显波动，恰逢异常的价格变动，但此处没有可关联到的具体新闻事件。

• 2026-08-05T00:00:00.000Zneutral

  CVS filed 10-Q

  可能与公司最新披露的财务与指引更新相关，但未必直接导致价格变动；需关注SEC filing内容的具体影响。

  Source: SEC EDGAR

• 2026-08-05T00:00:00.000Znegative

  Price move: CVS fell 5.1%

  CVS 在这段行情中出现明显波动，恰逢异常的价格变动，但此处没有可关联到的具体新闻事件。

Analyst view

Avg price target $114.3 from 10 analysts (last quarter)

Insider & Congress activity

订阅每日简报

每个交易日开盘/收盘后，中文市场简报直达邮箱。免费，随时退订。

本内容仅为信息整理，不构成任何投资建议。